three types of interindividual genetic variation that can influence pharmacotherapy
enzymes involved in drug metabolism that display polymorphism
what is the function of butyrylcholinesterase
it metabolizes succinylcholine
what occurs if there is a polymorphism in butyrylcholinesterase
-there would be a decreased rate of metabolism of succinylcholine leading to prolonged flaccid paralysis
type of inheritance of butyrylcholinesterase
hereditary autosomal recessive trait
how do you treat those with polymorphism in butyrylcholinesterase
you treat with continued mechanical ventilation until muscle function returns to normal
function of N acetyltransferase 2 and the types
inheritance of slow acetylators
autosomal recessive
adverse effects of slow acetylators
since it keeps drug in plasma high and longer, it causes toxicity
examples of slow acetylators effects on drugs
function of CYP2D6
it is part of the CYP450 family and hence metabolizes a lot of drugs
discuss different types of metabolizers of CYP2D6
name drugs that are metabolized by CYP2D6
what happens with poor metabolizers of CYP2D6 and give some examples
they suffer side effects when treated with standard doses as seen with metoprolol
or with codeine, it is ineffective since it needs to be converted by the enzyme to morphine
what happens when you give standard doses of codeine to ultrarapid metabolizers
overdose on codeine –> respiratory depression or respiratory arrest
what does thiopurine S-methyltransferase (TPMT) do
it methylates anti cancer drugs thiopurines 6 mercaptopurine and azathioprine which is good because they have a small therapeutic window
what happens then if one is homozygous for the polymorphism in TPMT (thiopurine S-methyltransferase)
they have to be given 1/10 of the standard dose so as not to have a toxic effects of the cancer drugs
when is EGFR (epidermal growth factor receptor) expressed
in non-small cell lung cancer (NCLC)
what drugs is approved for non-small cell lung cancer and how does it work
Gefitinib and it is an inhibitor of tyrosine kinase on EGFR
drug that is affected by both pharmocokinetics and pharmacodynamics
warfarin
lower doses of warfarin should be considered in what types of patients
those with polymorphism in CYP2C9 and VKORC1
how does racemic mixture of warfarin affects its metabolism
what is idiosyncratic effect a result of
interaction between the drug and unique aspect of the physiology of the individual patient
condition that causes an idiosyncratic adverse effect
G6PD deficiency –> formation of heinz bodies (oxidized hemoglobin)